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A B S T R A C T
The ability to cope successfully with stress is known as ‘resilience’, and those with resilience are not prone to
developing depression. One preclinical animal model for depression is the chronic mild stress (CMS) model.
There are CMS-resilient (do not manifest anhedonia) and CMS-susceptible (manifest anhedonia) rats. This study
aimed to investigate the differences in the profiles of hippocampal metabolites between susceptible and resilient
rats, and to identify a biomarker that can distinguish the two. We divided stress-loaded rats into susceptible and
resilient types based on their sucrose preference values. We then conducted brain-derived neurotrophic factor
(BDNF) quantification and metabolomic analysis in the hippocampus. Compared to the controls, no significant
differences were observed in the hippocampal BDNF levels of susceptible and resilient rats. However, the control
rats were clearly distinguishable from the susceptible rats in terms of their brain metabolite profiles; the control
rats were difficult to distinguish from the resilient rats. CMS model rats showed an increase in the levels of N-
acetylaspartate and glutamate, and a decrease in the levels of aspartate and γ-aminobutyric acid in the hippo-
campus. Of the 12 metabolites measured in the present study, N-acetylaspartate was the only one that could
differentiate the three types (control, susceptible, and resilient) of rats. Thus, brain metabolomic analyses can
not only distinguish CMS model rats from control rats, but also indicate stress susceptibility. The variation in the
levels of N-acetylaspartate in the hippocampus of control, resilient, and susceptible rats demonstrated that it
could be a biomarker for stress susceptibility.
1. Introduction
The World Health Organization announced in March 2018 that the
number of patients afflicted with depression has reached 300 million
globally [1]. Depression presents as a variety of symptoms including
insomnia, weight loss, fatigue, and loss of concentration, with de-
pressed mood and loss of interest or pleasure (anhedonia) being posi-
tioned as the core symptoms of depression [2]. Stressful life events such
as becoming a victim of crime, financial problems, and divorce are risk
factors for depression [3]. However, not everyone who has experienced
stressful life events develops depression; some people adapt to stress.
The ability to successfully adapt to stress is termed ‘resilience’ [4], and
individuals who have acquired resilience are believed to have active
coping capabilities towards stress [5].
A chronic mild stress (CMS) model created by chronic stress was
reported to have favourable construct, face, and predictive validity [6];
additionally, chronic stress is known to induce anhedonia, which is a
core symptom of depression [7]. In the CMS models, anhedonia has
been evaluated by a behavioural test known as the sucrose preference
test. However, CMS animal models require several weeks to be created;
they are also known to have poor reliability [8]. We previously con-
firmed that rats chronically loaded with stress experience a reduction in
sucrose preference (i.e., they present symptoms of anhedonia) [9].
However, not all rats exposed to stress exhibit a reduction in sucrose
preference [9,10]. This mixture of types is believed to underlie the poor
reliability of the animal model of depression created via chronic stress.
In addition, in CMS model rats, those that present with anhedonia are
said to be susceptible individuals, and those that do not are said to be
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resilient rats. These rats are used in studies on stress resilience [11,12].
Furthermore, it has been reported that responses to antidepressants
differ between low- and high-responders to stress [13,14,15]. It is
therefore important to adjust the behavioural characteristics of in-
dividual animals at a stage prior to stress loading.
A number of studies state that the hippocampus is involved not only
in memory and cognitive function, but also in mood regulation
[16,17,18]. Moreover, the hippocampus’ structure and function are
highly sensitive to stress [19,20]. Chronic stress is known to reduce the
level of brain-derived neurotrophic factor (BDNF), which is involved in
neuronal survival and synaptic plasticity within the hippocampus [21].
In addition, intrahippocampal injection of BDNF produces anti-
depressant-like effects. BDNF is also necessary for the effects of some
antidepressants [22,23]. A number of basic studies have demonstrated
that the concentration of BDNF in the hippocampus can be used as a
marker for a compound’s anti-depressive activity [24,25].
We have already found that profiles of brain metabolites of CMS
model rats can be clearly distinguished using high resolution magic
angle spinning 1H nuclear magnetic resonance (NMR) spectroscopy,
and reported that the metabolomic analysis can assess the stressed state
[9]. Based on our previous results, we assumed the poor reliability of
CMS models to be attributable to the intermixing of resilient rats with
susceptible rats. Therefore, in the current study, we opted to use re-
silient and susceptible rats that had undergone chronic loading of stress
to perform a metabolomic analysis of the rats’ hippocampal tissues, and
to investigate the differences in the profiles of brain metabolites be-
tween the resilient and susceptible states. We also aimed to identify
biomarkers that can distinguish between resilient and susceptible rats.
2. Materials and methods
2.1. Animals
We purchased 39 7-week-old male Wistar/ST rats from Sankyo Labo
Service Corporation, Inc. (Tokyo, Japan). The rats were acclimatized for
a minimum of one week at 25 ± 2 °C, relative humidity of 55 ± 5%,
with a 12-h light-dark cycle (7:00–19:00), and with ad libitum food (Lab
MR Stock; Nosan Corp., Kanagawa, Japan) and water intake. Of the 39
rats, 21 were randomly allocated to the Stressed Group, and the re-
maining 18 were allocated to the unstressed Control Group.
All animal experiments were performed in accordance with the
Guideline for Proper Conduct of Animal Experiments, established by
the Science Council of Japan after approval by the Institutional Animal
Care Committee of Josai University (approval number: H29102-2017/
10/5).
2.2. Establishment of chronic stress model rats
Chronic stress was implemented in accordance with previously re-
ported methods [9]. Fig. 1 presents the schedule of stress loading. Rats
in the Stressed Group were loaded with two types of stress (a combi-
nation of long-term stressors [> 12 h] and short-term stressors [≤ 1 h],
respectively) for 4 weeks (Days 2–29). Long-term stressors included
food and water deprivation (24 h), cage tilt (21 h, 45°), light during the
dark cycle (12 h), soiled cage (24 h), and water deprivation (conducted
for 24 h followed by 1-h empty bottle; total 25 h). Short-term stressors
included foot shock (1.5mA, 15 s per stimulation with 60 s intervals,
repeated eight times), forced swimming (5min at 4 °C), tail pinching
(1min), and white noise (85 dB, 15 s per stimulation with 15 s intervals,
repeated 120 times).
2.3. Body weight and behavioural testing
We performed body weight measurement and two types of beha-
vioural tests: sucrose preference and open field testing. The details are
provided below.
(1) Body weight: Measured between 9:00 and 9:30 once every 7 days
from Day 0 (pre-experiment), namely Days 7, 14, 21, and 28.
(2) Sucrose preference test: Conducted once every 7 days from Day 1
(pre-experiment), namely Days 8, 15, 22, and 29 [26]. A training
session to acclimatize the rats to the sucrose solution was conducted
72 h prior to the initial preference test, in which two bottles of 1%
sucrose solution were placed in each cage, and 24 h later the 1%
sucrose in one bottle was replaced with tap water for a further 24 h.
After acclimatization, the rats were deprived of food and water for
24 h, and then underwent a 24-hour sucrose preference test (Day 1).
The sucrose preference was calculated as a percentage of the con-
sumed 1% sucrose solution relative to the total volume of liquid
intake.
It was suggested that stress response varied for each individual ac-
cording to the behaviour of individual rats during the pre-experiment
stage. [27]. Therefore, to align the sucrose preference between the
Stressed Group and the Control Group, we excluded rats whose sucrose
preference in the pre-experiment was<80.0%.
Sucrose preference values are used to determine whether a rat is
susceptible or resilient to stress [11,12]. After the completion of a 4-
week stress load, rats in the Stressed Group whose sucrose preference
on Day 29 was< 65% were classified into the Susceptible Group, and
the remaining rats in the Stressed Group whose preference changes
from the pre-experiment stage were< 10% were classified into the
Resilient Group.
Fig. 1. Stress loading schedule.
Day 0 to Day 2 is the pre-experiment period. The stress loading period is from after implementation of the open field test (Day 2) to Day 29.
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(3) Open field test: In an open field test, rats are allowed to move
around and act freely in a quiet environment. We implemented this
test on Day 2 (pre-experiment) and Day 30, in accordance with
previously reported methods [28]. We used a plastic apparatus
(40 cm high) in which the pearl grey floor (100×100 cm) was
divided into 25 squares (each 20× 20 cm) by grey lines. Each rat
was gently placed in the centre of the apparatus and its behaviour
was video-recorded for 6min. The occurrences of grid line cross-
ings, rearing, defecation, and grooming in the recorded video
(5min; min 1–6) were counted to identify locomotor activities and
anxiety-like behaviours [29,30]. Open field was scored by hand by
observers blinded to the stress groups.
2.4. Sample preparation
After the final open field test, we decapitated the rats under an-
aesthesia (50mg/kg of pentobarbital sodium). After rapidly removing
the brain tissue, we separated the brain along the longitudinal cerebral
fissure into right and left hemispheres. The hippocampus in the right
and left brains, respectively, were dissected and quick-frozen using li-
quid nitrogen, then stored at −80 °C until the measurement dates. To
ensure constancy of the post-mortem changes in the brain metabolites,
we made sure to complete the entire set of operations within
10–15min.
2.5. Measurement of mature BDNF in the hippocampus
The hippocampus of the left hemisphere that had been frozen was
thawed under ice-cooling, placed inside a Teflon homogenizer, and had
the following items added per 10mg of wet weight: 100 μL of ice-cold
RIPA buffer containing 25mM Tris-HCl (pH 7.6), 150mM NaCl, 1%
Nonidet P-40, 1% sodium deoxycholate, 0.1% sodium dodecyl sulphate,
50 μM bestatin, 10 μM pepstatin A, 20 μM leupeptin hemisulphate, 0.8
μM aprotinin, 1 mM phenylmethylsulfonyl fluoride, and 2mM ethyle-
nediamine tetraacetic acid. After homogenizing under ice-cooling for
5min at 200 rpm, the homogenate was centrifuged at 4 °C, 14,000 × g,
for 30min. The supernatant was then collected. After diluting the su-
pernatant 500-fold in ice-cold RIPA buffer, we followed the manu-
facturer’s instructions and quantified the mature BDNF present in the
hippocampal tissue using the Mature BDNF, Human/Mouse/Rat, Rapid
ELISA Kit (Biosensis Pty Ltd., Australia). The standards and samples
were run in duplicate.
Protein quantification was performed using a bicinchoninic acid
assay (BCA protein assay kit-reducing agent compatible, Thermo
Scientific, MA, USA).
2.6. Measurement of the NMR spectra
We used a Varian INOVA-700 NMR instrument at 699.7MHz as the
1H frequency, equipped with a FASTNANO™ probe head (Agilent
Technologies, Santa Clara, CA, USA). To allow detection, 43 μL deut-
erated water containing 2.5mM sodium-3-(trimethylsilyl)-1-propane-
1,1,2,2,3,3-d 6-sulfonate was added to each hippocampus from the
right hemisphere (wet weight: 10–20mg). The sample was manually
homogenized with 20 rotations of a polypropylene pestle in a micro-
tube. After the entire volume of the brain homogenate was transferred
into a 43-μL glass cell with a Pasteur pipette, the cell was set into a
4mm outer diameter zirconium oxide rotor. This process was repeated
for each hippocampal sample. The rotors were then loaded into the
NMR spectrometer.
The parameters of the NMR spectrometer were as follows: 90° pulse
width, 7.50–7.75 μs (measured and set for each sample); relaxation
delay, 2.000 s; number of data points, 32k complex; observation width,
8389.3 Hz; number of scans, 128; and rotation speed, 5000 Hz A pre-
saturation sequence was performed to reduce water-derived signals. To
reduce broad signals derived from macromolecules such as proteins,
and to enable the conductance of subsequent analyses using small
molecules, we measured the NMR spectrum using the Carr-Purcell-
Meiboom-Gill spin-echo pulse sequence ([D-90°-(180°-) n-FID, where
FID is free induction decay] with a fixed spin-spin relaxation delay, 2
nτ, of 60ms [τ=400 μs]). Steps were taken to ensure consistency of
the changes in metabolites among the samples during measurements,
and the measurement temperature was maintained at 298 K. This op-
eration was carried out using VnmrJ software (Ver. 4.0; Agilent
Technologies).
2.7. Processing of the NMR spectra
After Fourier transformation of all acquired free induction decays,
we manually performed phase and baseline corrections using VnmrJ
software. The assignment of NMR data to metabolites was performed by
comparison with the Chenomx NMR Suite (Ver. 8.1, Chenomx Inc.,
Edmonton, AB, Canada) and previously reported spectra [31,32].
For multivariate analysis of NMR-derived data, all acquired free
induction decays were zero-filled to 32 k using Alice2 for Metabolome
software (Ver. 2; JEOL, Tokyo, Japan), and the absolute values were
differentiated following Fourier transformation. The chemical shift
range of 0.20–10.00 ppm (excluding the range of the water signal:
4.60–4.92 ppm) in the acquired NMR spectra was integrated in
0.04 ppm buckets to obtain 239 variables. Each bucket was then nor-
malized to yield a total integrated area of 100.
2.8. Statistical analysis
A two-tailed Student’s t-test was performed to compare the results of
body weight measurement and behavioural testing and the amount of
BDNF contained in the hippocampal tissues between the Control Group
and the Stressed Group. When performing a three-group comparison
among the Control Group, the Resilient Group, and the Susceptible
Group, one-way ANOVA or two-way repeated measures ANOVA fol-
lowed by a multiple comparison using Tukey-Kramer method was
conducted. We also subjected each of the NMR spectra buckets to the
Student’s t-test to identify relative changes in each brain metabolite. To
implement a two-tailed Student’s t-test, ANOVA, and a multiple com-
parison, we used R software (version 3.2.2, R Foundation for Statistical
Computing, Vienna, Austria) for Windows®.
To identify the differences in brain metabolite profiles, we con-
ducted a partial least squares discriminant analysis (PLS-DA), using
SIMCA-P multivariate analysis software (version 13.0.3, Umetrics,
Umea, Sweden). To avoid overfitting to the PLS-DA model, we con-
ducted a permutation test with 100 iterations [33].
3. Results
3.1. Establishment of CMS model rats
The results of the pre-experiment sucrose preference test indicated
that the sucrose preference exceeded 80.0% in 14 of the 18 rats in the
Control Group, and exceeded 80.0% in 18 of the 21 rats in the Stressed
Group. Fig. 2 presents the results of body weight and behavioural
testing in the pre-experiments and after 4 weeks of stress loading in the
Control Group (n= 14) and the Stressed Group (n=18).
A repeated measures ANOVA on Body Weight (Fig. 2A) showed that
the presence of stress [F(1,120)= 3668.5, P < 0.01] and the experi-
ment duration [F(4,120)= 634.08, P < 0.01] significantly influenced
body weight. Moreover, a statistical interaction was observed between
the presence or absence of stress and the experiment duration
[F(4,120)= 303.64, P < 0.01]. Likewise, with respect to sucrose pre-
ference (Fig. 2B), presence or absence of stress [F(1,120)= 12.446, P <
0.01] and the experiment duration [F(4,120)= 7.171, P < 0.01] sig-
nificantly influenced sucrose preference. A statistical interaction was
observed between the presence of stress and the experiment duration
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[F(4,120)= 6.013, P < 0.01].
In the pre-experiments, no significant differences were observed
between the Control Group and the Stressed Group in any of the six
evaluation items (sucrose preference, body weight, crossing, rearing,
defecation, and grooming), confirming that the behavioural features
were the same between the two groups (Fig. 2A–F).
While body weight decreased significantly immediately after stress
loading [Day 7: t(30)= 6.62, P < 0.01; Fig. 2A], sucrose preference
decreased significantly 4 weeks after starting the stress loading
[t(30)= 2.94, P < 0.05; Fig. 2B]. Crossing and rearing, both of which
are indicators of locomotor activity, decreased significantly due to
stress loading [t(30)= 6.01, P < 0.01 and t(30)= 2.54, P<0.05, re-
spectively; Fig. 2C and D]. Defecation, an indicator of anxiety, exhibited
a tendency to increase [t(30) = -1.74, P= 0.064; Fig. 2E], while
grooming, which is yet another indicator of anxiety, exhibited a sig-
nificant increase [t(30) = -5.20, P < 0.01; Fig. 2F]. Based on the
above, CMS model animals were created by chronic stress.
3.2. Detection of resilient rats based on sucrose preference values
Fig. 3 presents the distribution of sucrose preferences that were
measured every week from the pre-experiment period.
The sucrose preference of each rat in the Control Group, indicated
by a white circle, decreased in some rats. However, the majority of the
rats exhibited almost no changes in sucrose preference throughout the
4-week period. The sucrose preference of rats in the Stressed Group,
indicated by either a grey or a black circle, was distributed between
80% and 100% at the pre-experiment stage. However, after stress
loading, the rats in the Stressed Group were clearly divided into those
whose sucrose preference decreased with time (indicated by a black
circle) and those whose sucrose preference remained unchanged (in-
dicated by a grey circle). In our study, in line with previously reported
literature [12], the rats in the Stressed Group (n= 18, grey and black
circles, Fig. 3) whose sucrose preference on Day 29 was< 65% were
classified into the Susceptible Group (n= 8, black circle); of the re-
maining rats in the Stressed Group, those whose change in sucrose
preference was<10% were classified into the Resilient Group (n=9,
grey circle). However, one rat in the Stressed Group had a sucrose
preference of 74.0% as of Day 29 (Fig. 3; excluded). Because this rat did
not belong to either the Resilient Group or the Susceptible Group, it was
excluded from subsequent experiments.
After the Stressed Group had been divided into Resilient and
Susceptible Groups, the results of body weight and behavioural testing
were compared among the three groups: namely, the Control, Resilient,
and Susceptible Groups. The findings are presented in Fig. 4. Repeated
measures ANOVA on Body Weight (Fig. 4A) demonstrated that the
group [F(2,112)= 1737.33, P < 0.01] and the experiment duration
[F(4,112)= 622.91, P < 0.01] significantly influenced body weight.
Further, a statistical interaction was found between the group and the
experiment duration [F(8,112) = 141.68, P < 0.01].
One-way ANOVA on crossing, rearing, defecation, and grooming in
the pre-experiment stage demonstrated no significant difference in any
of the surveyed items: crossing [F(2,28)= 0.12, P= 0.89], rearing
[F(2,28)= 0.50, P= 0.61], defecation [F(2,28)= 0.42, P= 0.66], and
grooming [F(2,28)= 0.56, P= 0.58]. Therefore, at the pre-experiment
stage, no significant differences were observed among the Control,
Resilient, or Susceptible Groups, confirming that the behavioural fea-
tures were the same among the three groups (Fig. 4A–E).
One-way ANOVA on evaluation items of the open field test fol-
lowing the completion of 4-week stress load indicated significant dif-
ferences amongst three groups in crossing [F(2,28)= 16.16, P < 0.01],
rearing [F(2,28)= 4.21, P < 0.05], and grooming [F(2,28)= 12.09,
P < 0.01]. However, no significant differences were detected in de-
fecation [F(2,28)= 1.39, P= 0.27]. Subsequently, a multiple compar-
ison was conducted using Tukey-Kramer method. Thecrossing of the
Resilient Group and the Susceptible Group decreased significantly
compared to that of the Control Group (test statistic = 4.67, P < 0.01
and test statistic = 4.77, P < 0.01, respectively). However, no
Fig. 2. Influence of stress load on rats’ behaviours and actions.
Following two-way repeated measures ANOVA on body weight (A) and sucrose preference (B), the two-tailed student’s t-test was performed for each time point.
Regarding crossing (C), rearing (D), defecation (E), and grooming (F), the two-tailed student’s t-test was performed for the pre-experiment period and Day 30. All data
are presented as mean ± SEM. *: P < 0.05, **: P < 0.01. Con: Control Group (n = 14); Str: Stressed Group (n = 18).
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significant differences were observed between the Resilient Group and
the Susceptible Group (Fig. 4B). Rearing decreased significantly in the
Susceptible Group compared to the Control Group (test statistic= 2.85,
P < 0.05), but no significant differences were observed between the
Resilient Group and the Control Group (Fig. 4C). No significant dif-
ferences were seen in defecation among three groups (Fig. 4D).
Grooming in the Resilient Group and the Susceptible Group increased
significantly compared to that of the Control Group (test statistic=
4.32, P<0.01 and test statistic= 3.81, P < 0.01), but no significant
differences were observed between the Resilient Group and the Sus-
ceptible Group (Fig. 4E).
3.3. Amount of mature BDNF in the hippocampal tissues
Fig. 5 indicates the amount of mature BDNF in each group. The
amount of mature BDNF in the hippocampus was 4,507.6 ± 123.0 pg/
mg protein (mean ± SEM) in the control group and
4,722.9 ± 124.0 pg/mg protein in the Stressed Group, with no sig-
nificant difference between the two groups [t(29) = -1.22, P= 0.23;
Fig. 5A].
The Stressed Group was further divided into the Resilient Group and
the Susceptible Group, and one-way ANOVA was carried out on three
groups: Control, Resilient and Susceptible. However, no significance was
detected. The multiple comparison also revealed no significant differences
in the hippocampal BDNF among three groups. (Control Group=
Fig. 3. Timeline changes in sucrose preference
of individual rats.
The white circle indicates Control rats, and
either grey or black circles indicate rats in the
Stressed Group. The grey and black circles re-
present resilient rats and susceptible rats, re-
spectively. One rat in the Stressed Group
whose sucrose preference was 74.0% on Day
29 was excluded from the experiments.
Fig. 4. Changes in behaviours related to sensitivity to stress.
White circles represent the Control Group, grey circles represent the Resilient Group, and black circles represent the Susceptible Group. Following two-way repeated
measures ANOVA on body weight (A), a multiple comparison was conducted for each time point using Tukey-Kramer method. Regarding crossing (C), rearing (D),
defecation (E), and grooming (F), one-way ANOVA was performed for the pre-experiment period and Day 30, followed by a multiple comparison using Tukey-Kramer
method. All data are presented as mean ± SEM. *: P<0.05 compared to the Control Group, **: P < 0.01 compared to the Control Group. Con: Control Group (n =
14); Res: Resilient Group (n = 9); Sus: Susceptible Group (n = 8).
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4,507.6 ± 123.0 pg/mg protein, Resilient Group=4,725.6
± 200.8 pg/mg protein, and Susceptible Group=4,719.9 ± 151.4 pg/
mg protein; Fig. 5B).
3.4. Profiles of the brain metabolites of resilient and susceptible rats
Fig. 6 provides the profiles of the brain metabolites of the Control
Group and the Stressed Group, as well as their validity plot (permuta-
tion plot). We performed a PLS-DA on the NMR spectra’s bucket in-
tegral value and found that the brain metabolite profiles were distin-
guishable between the Control Group (white circle) and the Stressed
Group (black circle). However, the two groups could not be clearly
discriminated (Fig. 6A). All permuted R2Y values (goodness of fit:
green) and Q2 values (predictability: blue) on the left were lower than
the original point on the right (R2Y cum=0.679, Q2 cum=0.401:
Fig. 6B) [33]. Although the permutation plot supported the validity of
the PLS-DA model, predictability was low [34].
Fig. 7A and B provides the profiles of brain metabolites of the
Control Group and the Susceptible Group, as well as the permutation
plots. From Fig. 7A, the brain metabolite profiles of the Control Group
and the Susceptible Group were clearly distinguishable. Moreover, the
R2Y cum was 0.866 and the Q2 cum was 0.659 (Fig. 7B); hence, the
fitness and predictability were higher than those in the PLS-DA model
of the Control and Stressed Groups. Fig. 7C and D provides the brain
metabolite profiles and permutation plots of the Control Group and the
Resilient Group. From Fig. 7C, the brain metabolite profiles of the
Control Group and the Resilient Group were not clearly distinguishable.
From the permutation plots (Fig. 7D), the R2Y cum was 0.577, and the
Q2 cum was 0.243; hence, the fitness and predictability had fallen
below those of the PLS-DA model of the Control Group and the Stressed
Group.
3.5. Changes in each brain metabolite in the hippocampus
In this study, we were able to assign 12 kinds of brain metabolites to
the NMR spectra. Of these 12, we regarded brain metabolites with P-
Fig. 5. Comparison of the amount of mature BDNF in the hippocampal tissue.
Two-tailed student’s t-test was conducted to compare two groups (A). For comparison among 3 groups (B), one-way ANOVA was performed followed by a multiple
comparison using Tukey-Kramer method. All data are presented as mean ± SEM. Con: Control Group (n= 14); Str: Stressed Group (n=18); Res: Resilient Group
(n=9); Sus: Susceptible Group (n= 8); BDNF: brain-derived neurotrophic factor.
Fig. 6. Influence of stress loading on brain metabolite profiles.
(A) Partial least squares discriminant analysis (PLS-DA) score plot: White circles represent the Control Group and black circles represent the Stressed Group. (B)
Permutation plot with 100 iterations: Green circles represent fitness (R2Y cum=0.679) and blue boxes represent predictability (Q2 cum=0.401).
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values, as calculated by the Student’s t-test, of< 0.05, and lower limits
of the 95% confidence interval (CI) of the variable importance in the
projection (VIP) score of> 1.0, as ‘potential biomarker candidates
[35]’.
Table 1 (sorted in descending order with respect to VIP score) in-
dicates the relative changes in the brain metabolites in the Stressed
Group compared to those of the Control Group. Two metabolites had
increased significantly in the Stressed Group, namely N-acetylaspartate
Fig. 7. Changes in brain metabolite profiles in relation to sensitivity to stress.
(A) Partial least squares discriminant analysis (PLS-DA) score plot: The white circles represent the Control Group and the black circles represent the Susceptible
Group. (B) Corresponding permutation plot with 100 iterations: Green circles represent fitness (R2Y cum=0.866) and blue boxes represent predictability (Q2
cum=0.659). (C) PLS-DA score plot: White circles represent the Control Group and the grey circles represent the Resilient Group. (D) Corresponding permutation
plot with 100 iterations: The green circles represent fitness (R2Y cum=0.577) and the blue boxes represent predictability (Q2 cum=0.243).
Table 1
Relative changes in each brain metabolite.
Metabolite Chemical shift
(ppm)
Changed a
(fold difference b)
P value VIP score VIP score 95%CI
N-acetylaspartate 2.01, 2.49, 2.68 ↑ (1.26) < 0.01 9.01 7.74–10.27
GABA 1.90, 2.29, 3.01 ↓ (0.78) < 0.01 7.64 5.09–10.18
Phosphocholine 3.21, 3.58, 4.16 (1.04) 0.17 5.81 −0.58–12.21
Acetate 1.91 ↓ (0.86) < 0.01 4.40 2.53–6.27
Aspartate 2.68, 2.80, 3.89 ↓ (0.85) < 0.01 2.50 1.69–3.31
Lactate 1.32, 4.10 (1.01) 0.72 1.36 −3.70–6.42
Glutamine 2.14, 2.43, 3.77 (0.96) 0.09 0.84 −0.30–1.97
Myo-inositol 3.27, 3.52, 3.61 (1.02) 0.39 0.67 −0.29–1.62
Alanine 1.47, 3.77 (0.93) 0.11 0.36 −0.94–1.66
Glutamate 2.04, 2.12, 2.33 ↑ (1.07) 0.04 0.25 −0.04–0.54
Choline 3.19, 3.51, 4.05 (1.02) 0.69 0.22 −0.06–0.49
Creatine 3.03, 3.92 (1.00) 0.99 0.05 −0.65–0.76
Two-tailed student’s t-test was performed on the integrated bucket values of the NMR spectrums between the Control Group and the Stressed Group, to examine the
relative variation of brain metabolites. Metabolites with p < 0.05 and 95% CI lower limit of the VIP score>1.0 were considered to be potential biomarker
candidates. This table is sorted in descending order of VIP score. a Arrows represent an increase or decrease in the metabolite level compared to that of the control
group. b Fold differences were calculated by ratios of the mean of the integral value of each bucket and are presented in parentheses. GABA: γ-aminobutyric acid; VIP:
variable importance in projection; CI: confidence interval.
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[t(29) = -6.17, P < 0.01] and glutamate [t(29) = -2.20, P < 0.05];
and three kinds of metabolites had significantly decreased, namely γ-
aminobutyric acid [t(29)= 4.12, P < 0.01; GABA], acetate
[t(29)= 5.40, P < 0.01], and aspartate [t(29)= 7.70, P < 0.01]. Of
these five metabolites, the metabolites that had a 95% CI lower limit of
the VIP score> 1.0 were N-acetylaspartate, GABA, acetate, and as-
partate. Therefore, in this study, these four metabolites were identified
as potential biomarker candidates that could be used to distinguish
between the Control Group and the Stressed Group.
Fig. 8 indicates the changes in 12 brain metabolites among the
Control, Resilient, and Susceptible Groups. One-way ANOVA on each
brain metabolite revealed statistical significance in N-acetylaspartate
[F(2,30)= 46.80, P < 0.01], aspartate [F(2,30)= 32.11, P < 0.01],
GABA [F(2,30)= 12.84, P < 0.01], glutamate [F(2,30)= 3.96, P <
0.05], and acetate [F(2,30)= 16.63, P < 0.01] among the Control
Group, the Resilient Group, and the Susceptible Group. Subsequently, a
multiple comparison conducted on these five metabolites using Tukey-
Kramer method showed that N-acetylaspartate was the only metabolite
that not only increased under stress, but also significantly differed in
level between the Resilient Group and the Susceptible Group (all
pairwise comparisons = P < 0.01). No significant changes were seen
in aspartate (test statistic = 1.51, P= 0.30), GABA (test statistic =
1.55, P= 0.28), or acetate (test statistic = 1.59, P= 0.27) between
the Resilient Group and the Susceptible Group. Glutamate increased
significantly in the Susceptible Group compared to that in the Control
Group (P < 0.05). No significant changes were observed in any of the
remaining seven metabolites.
4. Discussion
In this study, we created preclinical depression model animals that
exhibited weight loss, anhedonia, reduced locomotor activity, and
increased anxiety as a result of 4-week stress loading. However, not all
of the stressed animals created herein presented with anhedonia, and
animals presenting with anhedonia (susceptible) and those not pre-
senting anhedonia (resilient) were mixed together. Susceptible rats
presenting with anhedonia exhibited significant decreases in locomotor
activities such as crossing and rearing, and a significant increase in
anxiety. Resilient rats exhibited a significant decrease in crossing, a
decreasing trend in rearing, and an increase in anxiety. Thus, these
findings suggest that locomotor activity and anxiety are susceptible to
stress regardless of whether the rats were resilient or not.
Mature BDNF alters neuronal survival and synaptic plasticity by
binding to tropomyosin-related kinase B (TrkB) receptors [21,36,37].
Atrophy of the hippocampus is observed in patients with major de-
pressive disorders (MDD), with reported BDNF involvement [38,39].
However, researchers have suggested that the BDNF in the hippo-
campus of MDD patients does not always decrease [40], and no con-
sistent data have been obtained. Mouse and rat BDNF gene consist of at
least eight 5′ noncoding exons (exons 1–8) and one protein coding 3′
exon. In each BDNF transcript, one 5′ exon is spliced to the protein
coding exon [41]. Ieraci et al. observed the hippocampus of mice ex-
hibiting depressive-like behaviour and reported that there were no
changes in BDNF and the total expression of BDNF mRNA, and there
was a decrease only in the BDNF-7 mRNA level, out of 8 splice variants
[42]. Therefore, while there was no decrease in hippocampal BDNF
level in CMS model rats created in this study, there could be a decrease
in BDNF splice variants. Moreover, it was suggested that the BDNF level
differs between the dorsal and ventral regions of the hippocampus de-
pending on whether the rats acquired resilience to the stress [43]. In
this study, since the ventral and dorsal regions of the hippocampus were
not studied separately, there is a limitation to assessing the impact of
CMS on hippocampal BDNF.
When assessing whether or not a compound acts against depressive-
Fig. 8. Relative changes in brain metabolites in relation to sensitivity to stress.
One-way ANOVA was performed for each brain metabolite, followed by a multiple comparison using Tukey-Kramer method. All data are presented as mean ± SEM.
*: P < 0.05, **: P<0.01. Con: Control Group (n= 14); Res: Resilient Group (n= 9); Sus: Susceptible Group (n= 8); GABA: γ-aminobutyric acid.
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like symptoms using depression model animals, there is a considerable
body of literature describing the use of not only the results of body
weight and behavioural tests, but also of the use of changes in BDNF in
the hippocampus as evaluation indices [25,44,45]. However, it is also
reported that BDNF does not always decrease in the hippocampus of
depression model rats that have been created by chronic stress [46]. In
this study, we created CMS model animals that manifest symptoms that
are close to those observed in clinical situations. However, changes in
mature BDNF in the hippocampus were not observed in the Stressed
Group or the Susceptible Group. That is, rats in the Stressed Group
manifested depression-like behaviours despite the normal amount of
mature BDNF in their hippocampus. Therefore, since no consistent data
have been obtained from the results of this study or the previously
published literature on changes in BDNF in the hippocampus of pre-
clinical model animals, it is difficult at the present time to evaluate
depressive-like states in relation to the changes in BDNF in the hippo-
campus or to evaluate the anti-depressive effects of a particular com-
pound.
It was suggested that the brain metabolite profiles of CMS model
rats (resilient rats and susceptible rats mixed together) differed from
those of the control rats. Previously reported studies demonstrated that
profiles of stressed rats and control rats could be clearly distinguished,
in contrast to the present study findings [47,48]. However, metabo-
lomic analyses on rats excluding resilient rats revealed a clearer dif-
ference in the profiles of brain metabolites between the susceptible rats
and the control rats. This implies that mixing in resilient rats made it
difficult to distinguish profiles of brain metabolites between CMS model
rats and control rats. In other words, brain metabolome analysis could
reflect the stress susceptibility.
In the hippocampal tissues of depression model animals that were
created in this study, N-acetylaspartate and glutamate levels increased,
whereas GABA, acetate, and aspartate levels decreased. Of these five
metabolites, four, with the exception of glutamate, were identified as
potential biomarker candidates. In addition, no significant differences
were observed in stress-induced behaviours such as crossing and
grooming, or in brain metabolites such as GABA, acetate, and aspartate,
between the Resilient Group and the Susceptible Group. This may imply
that these three metabolites may be useful biomarkers for anxiety-like
behaviours such as a decrease of crossing and an increase of grooming
[30,49].
N-acetylaspartate is present in neurons at high concentrations [50],
and is formed from aspartate and acetyl-CoA by aspartate N-acetyl-
transferase [51]. Acetyl CoA is formed from acetate and coenzyme A. N-
acetylaspartate is also known to be a neuronal density marker; thus, the
increase in N-acetylaspartate levels in the brain tissue reflects elevated
neuronal density [52,53]. Of the 12 metabolites, N-acetylaspartate ex-
hibited the greatest change (a 1.26-fold increase compared to that in
the control animals) and had the largest VIP score as well. This sup-
ported our previously published work [9], revealing reproducibility of
an increase of N-acetylaspartate in CMS model rats. However, some
studies found that N-acetylaspartate decreased in the brain of depres-
sion model animals [54,55], and there is no consistency in the variation
of N-acetylaspartate. Khar et al. and Han et al. demonstrated that N-
acetylaspartate in the hippocampus of stress-loaded rats started to in-
crease 24 h from the stress-loading event and gradually returned to the
original level [56,57]. In this study, since the sucrose preference test
was conducted over a 24-hour span, hippocampus dissection was car-
ried out after at least 24 h from the last stress-loading event. Thus, the
fact that consistency was not observed in the variation of N-acet-
ylaspartate in the hippocampus of depression model animals may stem
from the change in the levels of N-acetylaspartate with time. In this
study, aspartate and acetate, which are the substrates of aspartate N-
acetyltransferase, decreased significantly, and N-acetylaspartate, which
is the product, increased significantly. These findings suggest that, in
the hippocampus of animals in depressive-like states, the activity of
aspartate N-acetyltransferase may increase, and that the neuronal
density of the hippocampus may increase. Notably, it is reported that,
although depression patients may have reduced hippocampal volumes
[58], the hippocampal neuronal density increases by approximately
30% [59]. Moreover, the amount of N-acetylaspartate in the hippo-
campal tissue of resilient animals fell midway between those of control
animals and susceptible animals, suggesting that N-acetylaspartate is a
potential biomarker that can distinguish the Control, Resilient, and
Susceptible Groups.
GABA is formed from glutamate by glutamate decarboxylase (GAD).
GABA activates GABAA receptors in adult hippocampal progenitor cells.
Reportedly, activated GABAA receptors promote neurogenesis and
neuronal differentiation, by discharging intracellular Cl− and in-
creasing the concentration of Ca2+ [60,61]. Hemanth et al. reported a
decrease in GABA in the hippocampus of CMS model rats [62]. Like-
wise, GABA decreased significantly in the hippocampus of CMS model
rats created in this study. Moreover, the GAD substrate glutamate in-
creased in susceptible rats. These findings raise the possibility that,
under stressed state, hippocampal GAD activity could decrease [63] or
GABAergic neurons could decrease [64], and the rates of neurogenesis
and neuronal differentiation could decrease. Compared to the control
animals, both the resilient and susceptible animals exhibited a reduc-
tion in GABA. However, glutamate, which is a precursor of GABA, in-
creased only in susceptible animals. This suggests that, in a state that
manifests anhedonia, the activity of GAD may be more strongly sup-
pressed.
These considerations reveal that in hippocampal tissues in CMS
model rats created in this study, the levels of brain metabolites such as
N-acetylaspartate and GABA, which are markers of neuronal density,
neurogenesis, or neuronal differentiation, show variations. Thus, brain
metabolomic analyses can not only distinguish CMS model rats from
control rats, but also indicate the stress susceptibility. Furthermore, the
findings of this study suggest that, of the 12 metabolites, N-acet-
ylaspartate may be the only metabolite capable of evaluating the three
susceptibility states.
Declaration of Interest
The authors declare no conflict of interest.
Funding sources
This research did not receive any specific grants from funding
agencies in the public, commercial, or not-for-profit sectors.
Acknowledgements
Not applicable.
References
[1] World Health Organization. Fact Sheet on Depression. http://www.who.int/
mediacentre/factsheets/fs369/en/ (add date last accessed).
[2] S.H. Kennedy, Core symptoms of major depressive disorder: relevance to diagnosis
and treatment, Dialogues Clin. Neurosci. 10 (2008) 271–277.
[3] K.S. Kendler, L.M. Karkowski, C.A. Prescott, Causal relationship between stressful
life events and the onset of major depression, Am. J. Psychiatry 156 (1999)
837–841.
[4] S.S. Luthar, D. Cicchetti, B. Becker, The construct of resilience: a critical evaluation
and guidelines for future work, Child Dev. 71 (2000) 543–562.
[5] G. Wu, A. Feder, H. Cohen, J.J. Kim, S. Calderon, D.S. Charney, A.A. Mathé,
Understanding resilience, Front. Behav. Neurosci. 7 (2013) 10.
[6] P. Willner, Validity, reliability and utility of the chronic mild stress model of de-
pression: a 10-year review and evaluation, Psychopharmacology (Berl.) 134 (1997)
319–329.
[7] P. Willner, A. Towell, D. Sampson, S. Sophokleous, R. Muscat, Reduction of sucrose
preference by chronic unpredictable mild stress, and its restoration by a tricyclic
antidepressant, Psychopharmacology (Berl.) 93 (1987) 358–364.
[8] J.F. Cryan, C. Mombereau, In search of a depressed mouse: utility of models for
studying depression-related behaviour in genetically modified mice, Mol.
Psychiatry 9 (2004) 326–357.
H. Akimoto et al. Behavioural Brain Research 359 (2019) 342–352
350
[9] H. Akimoto, S. Oshima, K. Ohara, A. Negishi, H. Hiroyama, T. Nemoto,
D. Kobayashi, High-resolution magic-angle Spinning-1H-NMR spectroscopy-based
metabolic profiling of hippocampal tissue in rats with depression-like symptoms,
Biol. Pharm. Bull. 40 (2017) 789–796.
[10] J. Raya, C.E.N. Girardi, L.A. Esumi, L.B.T. Ferreira, D.C. Hipólide, Multiple trial
inhibitory avoidance acquisition and retrieval are resistant to chronic stress, Behav.
Processes 147 (2018) 28–32.
[11] J.L. Remus, L.T. Stewart, R.M. Camp, C.M. Novak, J.D. Johnson, Interaction of
metabolic stress with chronic mild stress in altering brain cytokines and sucrose
preference, Behav. Neurosci. 129 (2015) 321–330.
[12] W.H. Shao, S.H. Fan, Y. Lei, G.E. Yao, J.J. Chen, J. Zhou, H.B. Xu, H.P. Liu, B. Wu,
P. Zheng, L. Fang, P. Xie, Metabolomic identification of molecular changes asso-
ciated with stress resilience in the chronic mild stress rat model of depression,
Metabolomics 9 (2013) 433–443.
[13] A. Jama, M. Cecchi, N. Calvo, S.J. Watson, H. Akil, Inter-individual differences in
novelty-seeking behavior in rats predict differential responses to desipramine in the
forced swim test, Psychopharmacology (Berl.) 198 (2008) 333–340.
[14] A.G. Flores-Serrano, J. Zaldívar-Rae, H. Salgado, J.C. Pineda, Immobility time
during the forced swimming test predicts sensitivity to amitriptyline, whereas tra-
veled distance in the circular corridor indicates resistance to treatment in female
Wistar rats, Neuroreport 26 (2015) 233–238.
[15] J.M. Weiss, M.A. Cierpial, C.H. West, Selective breeding of rats for high and low
motor activity in a swim test: toward a new animal model of depression, Pharmacol.
Biochem. Behav. 61 (1998) 49–66.
[16] A. Mendrek, J. Monterosso, S.L. Simon, M. Jarvik, A. Brody, R. Olmstead,
C.P. Domier, M.S. Cohen, M. Ernst, E.D. London, Working memory in cigarette
smokers: comparison to non-smokers and effects of abstinence, Addict. Behav. 31
(2006) 833–844.
[17] L.K. Jacobsen, J.H. Krystal, W.E. Mencl, M. Westerveld, S.J. Frost, K.R. Pugh, Effects
of smoking and smoking abstinence on cognition in adolescent tobacco smokers,
Biol. Psychiatry 57 (2005) 56–66.
[18] A. Zhang, H. Sun, P. Wang, Y. Han, X. Wang, Recent and potential developments of
biofluid analyses in metabolomics, J. Proteomics 75 (2012) 1079–1088.
[19] B.S. McEwen, Stress and hippocampal plasticity, Annu. Rev. Neurosci. 22 (1999)
105–122.
[20] B.S. McEwen, Effects of adverse experiences for brain structure and function, Biol.
Psychiatry 48 (2000) 721–731.
[21] H. Yu, Z.Y. Chen, The role of BDNF in depression on the basis of its location in the
neural circuitry, Acta Pharmacol. Sin. 32 (2011) 3–11.
[22] T. Deltheil, B.P. Guiard, J. Cerdan, D.J. David, K.F. Tanaka, C. Repérant,
J.P. Guilloux, F. Coudoré, R. Hen, A.M. Gardier, Behavioral and serotonergic con-
sequences of decreasing or increasing hippocampus brain-derived neurotrophic
factor protein levels in mice, Neuropharmacology 55 (2008) 1006–1014.
[23] T. Deltheil, K. Tanaka, C. Reperant, R. Hen, D.J. David, A.M. Gardier, Synergistic
neurochemical and behavioural effects of acute intrahippocampal injection of
brain-derived neurotrophic factor and antidepressants in adult mice, Int. J.
Neuropsychopharmacol. 12 (2009) 905–915.
[24] X.Q. Chen, C.F. Li, S.J. Chen, W.N. Liang, M. Wang, S.S. Wang, S.Q. Dong, L.T. Yi,
C.D. Li, The antidepressant-like effects of Chaihu Shugan San: dependent on the
hippocampal BDNF-TrkB-ERK/Akt signaling activation in perimenopausal depres-
sion-like rats, Biomed. Pharmacother. 105 (2018) 45–52.
[25] Y. Lu, C.S. Ho, R.S. McIntyre, W. Wang, R.C. Ho, Effects of vortioxetine and
fluoxetine on the level of Brain Derived Neurotrophic Factors (BDNF) in the hip-
pocampus of chronic unpredictable mild stress-induced depressive rats, Brain Res.
Bull. 142 (2018) 1–7.
[26] W. Liu, H. Sheng, Y. Xu, Y. Liu, J. Lu, X. Ni, Swimming exercise ameliorates de-
pression-like behavior in chronically stressed rats: relevant to proinflammatory
cytokines and IDO activation, Behav. Brain Res. 242 (2013) 110–116.
[27] F. Duclot, F. Hollis, M.J. Darcy, M. Kabbaj, Individual differences in novelty-seeking
behavior in rats as a model for psychosocial stress-related mood disorders, Physiol.
Behav. 104 (2011) 296–305.
[28] X. Zhu, O. Xia, W. Han, M. Shao, L. Jing, Q. Fan, Y. Liu, J. Diao, Z. Lv, X. Sun, Xiao
Yao San improves depressive-like behavior in rats through modulation of β-arrestin
2-mediated pathways in hippocampus, Evid. Complement. Alternat. Med. (2014)
(2014) 902516.
[29] F.M. Qiu, X.M. Zhong, Q.Q. Mao, Z. Huang, Antidepressant-like effects of paeoni-
florin on the behavioural, biochemical, and neurochemical patterns of rats exposed
to chronic unpredictable stress, Neurosci. Lett. 541 (2013) 209–213.
[30] A.V. Kalueff, P. Tuohimaa, Mouse grooming microstructure is a reliable anxiety
marker bidirectionally sensitive to GABAergic drugs, Eur. J. Pharmacol. 508 (2005)
147–153.
[31] L. Sun, J. Li, K. Zhou, M. Zhang, J. Yang, Y. Li, B. Ji, Z. Zhang, H. Zhu, L. Yang,
G. He, L. Gao, Z. Wei, K. Wang, X. Han, W. Liu, L. Tan, Y. Yu, L. He, C. Wan,
Metabolomic analysis reveals metabolic disturbance in the cortex and hippocampus
of subchronic MK-801 treated rats, PLoS One 8 (2013) e60598.
[32] M.J. Lan, G.A. McLoughlin, J.L. Griffin, T.M. Tsang, J.T. Huang, P. Yuan, H. Manji,
E. Holmes, S. Bahn, Metabonomic analysis identifies molecular changes associated
with the pathophysiology and drug treatment of bipolar disorder, Mol. Psychiatry
14 (2009) 269–279.
[33] C. Ke, A. Li, Y. Hou, M. Sun, K. Yang, J. Cheng, J. Wang, T. Ge, F. Zhang, Q. Li, J. Li,
Y. Wu, G. Lou, K. Li, Metabolic phenotyping for monitoring ovarian cancer patients,
Sci. Rep. 6 (2016) 23334.
[34] H. Li, B. Chen, X. Shao, Z. Hu, Y. Deng, R. Zhu, Y. Li, B. Zhang, J. Hou, C. Du,
Q. Zhao, D. Fu, Q. Bu, Y. Zhao, X. Cen, 1H-Nuclear magnetic resonance-based
metabolomic analysis of brain in mice with nicotine treatment, BMC Neurosci. 15
(2014) 32.
[35] M. Sun, X. Gao, D. Zhang, C. Ke, Y. Hou, L. Fan, R. Zhang, H. Liu, K. Li, B. Yu,
Identification of biomarkers for unstable angina by plasma metabolomic profiling,
Mol. Biosyst. 9 (2013) 3059–3067.
[36] A. Yoshii, M. Constantine-Paton, Postsynaptic BDNF-TrkB signaling in synapse
maturation, plasticity, and disease, Dev. Neurobiol. 70 (2010) 304–322.
[37] Y. Lu, K. Christian, B. Lu, BDNF: a key regulator for protein synthesis-dependent
LTP and long-term memory? Neurobiol. Learn. Mem. 89 (2008) 312–323.
[38] M. Stratmann, C. Konrad, H. Kugel, A. Krug, S. Schöning, P. Ohrmann, C. Uhlmann,
C. Postert, T. Suslow, W. Heindel, V. Arolt, T. Kircher, U. Dannlowski, Insular and
hippocampal gray matter volume reductions in patients with major depressive
disorder, PLoS One 9 (2014) e102692.
[39] T. Frodl, C. Schüle, G. Schmitt, C. Born, T. Baghai, P. Zill, R. Bottlender,
R. Rupprecht, B. Bondy, M. Reiser, H.J. Möller, E.M. Meisenzahl, Association of the
brain-derived neurotrophic factor Val66Met polymorphism with reduced hippo-
campal volumes in major depression, Arch. Gen. Psychiatry 64 (2007) 410–416.
[40] A. Sheldrick, S. Camara, M. Ilieva, P. Riederer, T.M. Michel, Brain-derived neuro-
trophic factor (BDNF) and neurotrophin 3 (NT3) levels in post-mortem brain tissue
from patients with depression compared to healthy individuals - a proof of concept
study, Eur. Psychiatry 46 (2017) 65–71.
[41] T. Aid, A. Kazantseva, M. Piirsoo, K. Palm, T. Timmusk, Mouse and rat BDNF gene
structure and expression revisited, J. Neurosci. Res. 85 (2007) 525–535.
[42] A. Ieraci, A. Mallei, M. Popoli, Social isolation stress induces anxious-depressive-
Like behavior and alterations of neuroplasticity-related genes in adult male mice,
Neural Plast. (2016) (2016) 6212983.
[43] M.P. Serra, L. Poddighe, M. Boi, F. Sanna, M.A. Piludu, M.G. Corda, O. Giorgi,
M. Quartu, Expression of BDNF and trkB in the hippocampus of a rat genetic model
of vulnerability (Roman low-avoidance) and resistance (Roman high-avoidance) to
stress-induced depression, Brain Behav. 7 (2017) e00861.
[44] J.M. Wang, L.X. Pei, Y.Y. Zhang, Y.X. Cheng, C.L. Niu, Y. Cui, W.S. Feng, G.F. Wang,
Ethanol extract of Rehmannia glutinosa exerts antidepressant-like effects on a rat
chronic unpredictable mild stress model by involving monoamines and BDNF,
Metab. Brain Dis. 33 (2018) 885–892.
[45] R.H. Mu, X.Y. Fang, S.S. Wang, C.F. Li, S.M. Chen, X.M. Chen, Q. Liu, Y.C. Li, L.T. Yi,
Antidepressant-like effects of standardized gypenosides: involvement of brain-de-
rived neurotrophic factor signaling in hippocampus, Psychopharmacology (Berl.)
233 (2016) 3211–3221.
[46] M. Stepanichev, A. Manolova, D. Peregud, M. Onufriev, S. Freiman, V. Aniol,
Y. Moiseeva, M. Novikova, N. Lazareva, N. Gulyaeva, Specific activity features in
the forced swim test: brain neurotrophins and development of stress-induced de-
pressive-like behaviour in rats, Neuroscience 375 (2018) 49–61.
[47] Y. Zhang, S. Yuan, J. Pu, L. Yang, X. Zhou, L. Liu, X. Jiang, H. Zhang, T. Teng,
L. Tian, P. Xie, Integrated metabolomics and proteomics analysis of Hippocampus in
a rat model of depression, Neuroscience 371 (2018) 207–220.
[48] H. Du, K. Wang, L. Su, H. Zhao, S. Gao, Q. Lin, X. Ma, B. Zhu, X. Dong, Z. Lou,
Metabonomic identification of the effects of the Zhimu-Baihe saponins on a chronic
unpredictable mild stress-induced rat model of depression, J. Pharm. Biomed. Anal.
128 (2016) 469–479.
[49] M.L. Seibenhener, M.C. Wooten, Use of the Open Field Maze to measure locomotor
and anxiety-like behavior in mice, J. Vis. Exp. 96 (2015) e52434.
[50] J. Urenjak, S.R. Williams, D.G. Gadian, M. Noble, Specific expression of N-acet-
ylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature
oligodendrocytes in vitro, J. Neurochem. 59 (1992) 55–61.
[51] E. Wiame, D. Tyteca, N. Pierrot, F. Collard, M. Amyere, G. Noel, J. Desmedt,
M.C. Nassogne, M. Vikkula, J.N. Octave, M.F. Vincent, P.J. Courtoy, E. Boltshauser,
E. van Schaftingen, Molecular identification of aspartate N-acetyltransferase and its
mutation in hypoacetylaspartia, Biochem. J. 425 (2009) 127–136.
[52] J.R. Moffett, B. Ross, P. Arun, C.N. Madhavarao, A.M. Namboodiri, N-
Acetylaspartate in the CNS: from neurodiagnostics to neurobiology, Prog.
Neurobiol. 81 (2007) 89–131.
[53] M. Nakano, H. Ueda, J.Y. Li, M. Matsumoto, T. Yanagihara, Measurement of re-
gional N-acetylaspartate after transient global ischemia in gerbils with and without
ischemic tolerance: an index of neuronal survival, Ann. Neurol. 44 (1998) 334–340.
[54] B. Czéh, T. Michaelis, T. Watanabe, J. Frahm, G. de Biurrun, M. van Kampen,
A. Bartolomucci, E. Fuchs, Stress-induced changes in cerebral metabolites, hippo-
campal volume, and cell proliferation are prevented by antidepressant treatment
with tianeptine, Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 12796–12801.
[55] G. Xi, J. Hui, Z. Zhang, S. Liu, X. Zhang, G. Teng, K.C. Chan, E.X. Wu, B. Nie,
B. Shan, L. Li, G.P. Reynolds, Learning and memory alterations are associated with
hippocampal N-acetylaspartate in a rat model of depression as measured by 1H-
MRS, PLoS One 6 (2011) e28686.
[56] A.R. Khan, B. Hansen, O. Wiborg, C.D. Kroenke, S.N. Jespersen, Diffusion MRI and
MR spectroscopy reveal microstructural and metabolic brain alterations in chronic
mild stress exposed rats: a CMS recovery study, Neuroimage 167 (2018) 342–353.
[57] F. Han, B. Xiao, L. Wen, Y. Shi, Effects of fluoxetine on the amygdala and the
hippocampus after administration of a single prolonged stress to male Wistar rates:
in vivo proton magnetic resonance spectroscopy findings, Psychiatry Res. 232
(2015) 154–161.
[58] S. Campbell, M. Marriott, C. Nahmias, G.M. MacQueen, Lower hippocampal volume
in patients suffering from depression: a meta-analysis, Am. J. Psychiatry 161 (2004)
598–607.
[59] C.A. Stockmeier, G.J. Mahajan, L.C. Konick, J.C. Overholser, G.J. Jurjus,
H.Y. Meltzer, H.B. Uylings, L. Friedman, G. Rajkowska, Cellular changes in the
postmortem hippocampus in major depression, Biol. Psychiatry 56 (2004) 640–650.
[60] Y. Tozuka, S. Fukuda, T. Namba, T. Seki, T. Hisatsune, GABAergic excitation pro-
motes neuronal differentiation in adult hippocampal progenitor cells, Neuron 47
(2005) 803–815.
H. Akimoto et al. Behavioural Brain Research 359 (2019) 342–352
351
[61] M. Sibbe, A. Kulik, GABAergic regulation of adult hippocampal neurogenesis, Mol.
Neurobiol. 54 (2017) 5497–5510.
[62] B.S. Hemanth Kumar, S.K. Mishra, P. Rana, S. Singh, S. Khushu, Neurodegenerative
evidences during early onset of depression in CMS rats as detected by proton
magnetic resonance spectroscopy at 7 T, Behav. Brain Res. 232 (2012) 53–59.
[63] M. Banasr, A. Lepack, C. Fee, V. Duric, J. Maldonado-Aviles, R. DiLeone, E. Sibille,
R.S. Duman, G. Sanacora, Characterization of GABAergic marker expression in the
chronic unpredictable stress model of depression, Chronic Stress (Thousand Oaks) 1
(2017), https://doi.org/10.1177/2470547017720459.
[64] B. Czéh, Z.K. Varga, K. Henningsen, G.L. Kovács, A. Miseta, O. Wiborg, Chronic
stress reduces the number of GABAergic interneurons in the adult rat hippocampus,
dorsal-ventral and region-specific differences, Hippocampus 25 (2015) 393–405.
H. Akimoto et al. Behavioural Brain Research 359 (2019) 342–352
352
